Cargando…
The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review
RATIONALE: Selective serotonin reuptake inhibitors (SSRIs), one of the commonly used anti-anxiety drugs, may have impacts on bone metabolism and potentially lead to drug-induced osteoporosis. The traditional approach of oral implantation in individuals with both anxiety disorder and drug-induced ost...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637472/ https://www.ncbi.nlm.nih.gov/pubmed/37960737 http://dx.doi.org/10.1097/MD.0000000000035905 |
_version_ | 1785146505789702144 |
---|---|
author | Li, Zhixin Yang, Chao Wang, Jinrong Zheng, Kaiyue Luo, Wen |
author_facet | Li, Zhixin Yang, Chao Wang, Jinrong Zheng, Kaiyue Luo, Wen |
author_sort | Li, Zhixin |
collection | PubMed |
description | RATIONALE: Selective serotonin reuptake inhibitors (SSRIs), one of the commonly used anti-anxiety drugs, may have impacts on bone metabolism and potentially lead to drug-induced osteoporosis. The traditional approach of oral implantation in individuals with both anxiety disorder and drug-induced osteoporosis poses a significant challenge. To address this issue, concentrated growth factor (CGF) has been utilized in patients undergoing concurrent alveolar ridge augmentation during oral implantation, resulting in favorable clinical outcomes. Consequently, combining CGF with guided bone regeneration (GBR) in alveolar bone increment may represent a promising new surgical approach for such patients. In this report, we present a case study of a 25-year-old male with anxiety disorder and drug-induced osteoporosis, in who CGF combined with GBR was employed in alveolar bone increment. PATIENT CONCERNS: This article reports the case of a 25-year-old male who underwent cone beam computed tomography (CBCT) due to the absence of his right lower second molar for a period of six months. The CBCT scan revealed significant bone defects, which were attributed to the tooth loss and prolonged use of anti-anxiety drugs. Consequently, the patient sought medical assistance from our department. DIAGNOSES: Based on the patient's self-report, he was diagnosed with an anxiety disorder. Additionally, the CBCT scan confirmed the loss of the right mandibular second molar and revealed the presence of dental irregularity and an alveolar bone defect. INTERVENTIONS: During the patient's course of treatment with anti-anxiety medication, a combination of CGF and GBR was employed for the simultaneous implantation of the missing right mandibular second molar, along with bone augmentation. OUTCOMES: The patient had a follow-up visit two weeks after the surgical procedure, and the wound in the operation area had healed satisfactorily. Six months later, CBCT images revealed excellent osseointegration. The buccal and lingual width of the alveolar bone measured 6.95mm, which was an increase of 1.35mm compared to the pre-implantation stage. LESSONS: This article presents a case study in which CGF combined with GBR were utilized to address alveolar bone augmentation during the implantation phase in patients taking anti-anxiety medication. The results demonstrated that CGF combined with GBR, as a cutting-edge platelet concentrate technique, could effectively stimulate bone tissue proliferation in individuals who have been on long-term anti-anxiety medication, specifically in oral implant areas. This approach can help prevent poor osseointegration, promote higher osseointegration rates, and facilitate wound healing. |
format | Online Article Text |
id | pubmed-10637472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-106374722023-11-15 The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review Li, Zhixin Yang, Chao Wang, Jinrong Zheng, Kaiyue Luo, Wen Medicine (Baltimore) 5900 RATIONALE: Selective serotonin reuptake inhibitors (SSRIs), one of the commonly used anti-anxiety drugs, may have impacts on bone metabolism and potentially lead to drug-induced osteoporosis. The traditional approach of oral implantation in individuals with both anxiety disorder and drug-induced osteoporosis poses a significant challenge. To address this issue, concentrated growth factor (CGF) has been utilized in patients undergoing concurrent alveolar ridge augmentation during oral implantation, resulting in favorable clinical outcomes. Consequently, combining CGF with guided bone regeneration (GBR) in alveolar bone increment may represent a promising new surgical approach for such patients. In this report, we present a case study of a 25-year-old male with anxiety disorder and drug-induced osteoporosis, in who CGF combined with GBR was employed in alveolar bone increment. PATIENT CONCERNS: This article reports the case of a 25-year-old male who underwent cone beam computed tomography (CBCT) due to the absence of his right lower second molar for a period of six months. The CBCT scan revealed significant bone defects, which were attributed to the tooth loss and prolonged use of anti-anxiety drugs. Consequently, the patient sought medical assistance from our department. DIAGNOSES: Based on the patient's self-report, he was diagnosed with an anxiety disorder. Additionally, the CBCT scan confirmed the loss of the right mandibular second molar and revealed the presence of dental irregularity and an alveolar bone defect. INTERVENTIONS: During the patient's course of treatment with anti-anxiety medication, a combination of CGF and GBR was employed for the simultaneous implantation of the missing right mandibular second molar, along with bone augmentation. OUTCOMES: The patient had a follow-up visit two weeks after the surgical procedure, and the wound in the operation area had healed satisfactorily. Six months later, CBCT images revealed excellent osseointegration. The buccal and lingual width of the alveolar bone measured 6.95mm, which was an increase of 1.35mm compared to the pre-implantation stage. LESSONS: This article presents a case study in which CGF combined with GBR were utilized to address alveolar bone augmentation during the implantation phase in patients taking anti-anxiety medication. The results demonstrated that CGF combined with GBR, as a cutting-edge platelet concentrate technique, could effectively stimulate bone tissue proliferation in individuals who have been on long-term anti-anxiety medication, specifically in oral implant areas. This approach can help prevent poor osseointegration, promote higher osseointegration rates, and facilitate wound healing. Lippincott Williams & Wilkins 2023-11-10 /pmc/articles/PMC10637472/ /pubmed/37960737 http://dx.doi.org/10.1097/MD.0000000000035905 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | 5900 Li, Zhixin Yang, Chao Wang, Jinrong Zheng, Kaiyue Luo, Wen The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review |
title | The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review |
title_full | The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review |
title_fullStr | The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review |
title_full_unstemmed | The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review |
title_short | The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review |
title_sort | application of cgf combined with gbr in alveolar bone increment for patients with anxiety disorder: a rare case report and literature review |
topic | 5900 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637472/ https://www.ncbi.nlm.nih.gov/pubmed/37960737 http://dx.doi.org/10.1097/MD.0000000000035905 |
work_keys_str_mv | AT lizhixin theapplicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview AT yangchao theapplicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview AT wangjinrong theapplicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview AT zhengkaiyue theapplicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview AT luowen theapplicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview AT lizhixin applicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview AT yangchao applicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview AT wangjinrong applicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview AT zhengkaiyue applicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview AT luowen applicationofcgfcombinedwithgbrinalveolarboneincrementforpatientswithanxietydisorderararecasereportandliteraturereview |